Quarterly Activities Report and Appendix 4C - Sep-2026 Qtr
Filed with ASX · · 11 pages · English
Summary by 6ix AI
The report highlights a revenue increase compared to the previous quarter, alongside a decrease in net operating cash outflows and a cash balance that supports several quarters of operations. The company is focusing on expanding its market presence in cancer survivorship and has made significant changes in its sales leadership to enhance performance. Additionally, the report outlines the company's strategic initiatives in heart health and body composition, aiming to capture new opportunities in these segments.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Impedimed
- Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
- Oversubscribed Share Purchase Plan Successfully Completed
- CEO Business Update
- Equity Raising Investor Presentation
- ImpediMed announces a successful $15.2 million Capital Raise
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed